Xue Yuan, Sun Angela, Mekikian P Betty, Martin Jorge, Rimoin David L, Lachman Ralph S, Wilcox William R
Department of Human Genetics, Emory University Atlanta, Georgia, 30322.
Medical Genetics Institute, Cedars-Sinai Medical Center Los Angeles, California.
Mol Genet Genomic Med. 2014 Nov;2(6):497-503. doi: 10.1002/mgg3.96. Epub 2014 Aug 5.
Fibroblast growth factor receptor 3 (FGFR3) is the only gene known to cause achondroplasia (ACH), hypochondroplasia (HCH), and thanatophoric dysplasia types I and II (TD I and TD II). A second, as yet unidentified, gene also causes HCH. In this study, we used sequencing analysis to determine the frequency of FGFR3 mutations for each phenotype in 324 cases from the International Skeletal Dysplasia Registry (ISDR). Our data suggest that there is a considerable overlap of genotype and phenotype between ACH and HCH. Thus, it is important to test for mutations found in either disorder when ACH or HCH is suspected. Only two of 29 cases with HCH did not have an identified mutation in FGFR3, much less than previously reported. We recommend testing other mutations in FGFR3, instead of just the common HCH mutation, p.Asn540Lys. The mutation frequency for TD I and TD II in the largest series of cases to date are also reported. This study provides valuable information on FGFR3 mutation frequency of four skeletal dysplasias for clinical diagnostic laboratories and clinicians.
成纤维细胞生长因子受体3(FGFR3)是已知唯一可导致软骨发育不全(ACH)、低软骨发育不全(HCH)以及Ⅰ型和Ⅱ型致死性发育异常(TD Ⅰ和TD Ⅱ)的基因。另一个尚未明确的基因也可导致HCH。在本研究中,我们采用测序分析来确定国际骨骼发育异常登记处(ISDR)324例病例中每种表型的FGFR3突变频率。我们的数据表明,ACH和HCH之间在基因型和表型上存在相当大的重叠。因此,当怀疑患有ACH或HCH时,检测这两种疾病中发现的突变很重要。29例HCH病例中只有2例未发现FGFR3突变,远低于先前报道。我们建议检测FGFR3中的其他突变,而不仅仅是常见的HCH突变p.Asn540Lys。本文还报道了迄今为止最大系列病例中TD Ⅰ和TD Ⅱ的突变频率。本研究为临床诊断实验室和临床医生提供了有关四种骨骼发育异常的FGFR3突变频率的宝贵信息。